Trogarzo (ibalizumab-uiyk): A Novel Monoclonal Antibody Used for Salvage Therapy in Patients Living with Highly Drug-Resistant HIV Infection
Publication Date
2019
Publication Title
ACCP StuNews
Recommended Citation
Anderson, K., & Kavanagh, R. K. (2019). Trogarzo (ibalizumab-uiyk): A Novel Monoclonal Antibody Used for Salvage Therapy in Patients Living with Highly Drug-Resistant HIV Infection. ACCP StuNews, 38, 5–8.
COinS